Wealth Enhancement Advisory Services
ROIV icon

Wealth Enhancement Advisory Services’s Roivant Sciences ROIV Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Buy
40,367
+4,518
+13% +$134K ﹤0.01% 1805
2026
Q1 		$1.02M Buy
35,849
+16,799
+88% +$432K ﹤0.01% 1786
2025
Q4 		$412K Buy
+19,050
New +$376K ﹤0.01% 2633

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Wealth Enhancement Advisory Services's ROIV Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Roivant Sciences (ROIV) stake by 13% in Q2 2026, buying an estimated $134K and bringing the position to 40,367 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #1805.

Wealth Enhancement Advisory Services first reported a position in ROIV in Q4 2025 and has held it in 3 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Wealth Enhancement Advisory Services held 40,367 shares of Roivant Sciences worth $1.45M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 4,518 Roivant Sciences shares in Q2 2026, an estimated $134K.
  • Roivant Sciences made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #1805 holding.
  • Wealth Enhancement Advisory Services first reported a position in Roivant Sciences in Q4 2025 and has held it in 3 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.